Brand Name | Status | Last Update |
---|---|---|
festal plus | unapproved drug other | 2018-11-22 |
reltone 200 mg reltone 400 mg | ANDA | 2023-01-16 |
urso 250 urso forte | New Drug Application | 2023-01-12 |
urso urso forte | 2008-05-27 | |
ursodiol | ANDA | 2025-03-13 |
ursodiol 200 mg ursodiol 400 mg | ANDA | 2024-11-26 |
ursodiol capsules | ANDA | 2010-05-25 |
urusa | unapproved drug other | 2018-11-19 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
biliary liver cirrhosis | — | D008105 | K74.3 |
cholelithiasis | EFO_0004799 | D002769 | K80 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
Drug common name | Ursodiol |
INN | ursodeoxycholic acid |
Description | Ursodeoxycholic acid is a bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones. It has a role as a human metabolite and a mouse metabolite. It is a bile acid, a dihydroxy-5beta-cholanic acid and a C24-steroid. It is a conjugate acid of an ursodeoxycholate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C |
PDB | — |
CAS-ID | 128-13-2 |
RxCUI | — |
ChEMBL ID | CHEMBL1551 |
ChEBI ID | 9907 |
PubChem CID | 31401 |
DrugBank | DB01586 |
UNII ID | 724L30Y2QR (ChemIDplus, GSRS) |